与 pembrolizumab相关的肝胆道疾病:使用FDA不良事件报告系统 (FAERS) 的现实世界药监测研究
Likun Ding1, Ning Ma1, Meiyou Liu1
1Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.
Drug research
|August 18, 2025
概括
根据FAERS数据,布罗利祖马布治疗与肝胆道疾病有关. 监测这些不良事件至关重要,特别是在治疗的前三个月内.
科学领域:
- 药物监督 药物监督 药物监督
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
背景情况:
- 布罗利祖马布是一种用于癌症治疗的免疫疗法药物.
- 肝胆道疾病是与药物治疗相关的潜在不良事件.
- 了解这些风险对于患者安全至关重要.
研究的目的:
- 评估与pembrolizumab相关的肝胆不良事件.
- 分析来自食品和药物管理局不良事件报告系统 (FAERS) 的数据.
主要方法:
- 利用了2009年第一季度至2024年第三季度的FAERS数据.
- 员工报告信号检测的概率比率 (ROR).
- 应用了不成比例分析和信号优先级的评级尺度.
主要成果:
- 布罗利祖马布治疗与肝胆道疾病有显著的关联.
- 检测到101个潜在的不良事件信号,其中56个被认为是显著的.
- 这些事件的中位数发病时间为63天,大多数发生在三个月内.
结论:
- 药监数据证实了与pembrolizumab相关的肝胆不良事件.
- 建议根据 pembrolizumab 指示对这些事件进行密切监测和管理.
- 在 pembrolizumab 治疗期间,医疗保健提供者应警肝胆毒性.
更多相关视频
11:36Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
3.1K
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
1.4K
相关概念视频
Pharmacovigilance
989
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
989
Drugs for Treatment of Constipation-Predominant IBS
331
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
331
Diseases of the Liver and Gallbladder
976
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
976
